Onderneming Arcutis Biotherapeutics, Inc.
Aandelen
ARQT
US03969K1088
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,365 USD | -3,41% | -8,68% | +158,98% |
15/05 | ARCUTIS BIOTHERAPEUTICS, INC. : Needham & Co. herhaalt koopadvies | ZM |
15/05 | ARCUTIS BIOTHERAPEUTICS, INC. : Mizuho Securities bevestigt koopadvies | ZM |
Vakgebied
Aantal werknemers: 296
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Dermatological Treatments
100,0
%
| 4 | 100,0 % | 60 | 100,0 % | +1.517,09% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 60 | 100,0 % | +1.517,09% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 56 | 01-01-16 |
Rajvir Madan
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-21 |
Jay Ramsinghani
COO | Chief Operating Officer | - | 27-05-20 |
Patrick Burnett
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-08-20 |
Courtney Barton
CMP | Compliance Officer | 41 | 18-02-21 |
Howard Welgus
BRD | Director/Board Member | 72 | 01-01-16 |
Ayisha Jeter
SAM | Sales & Marketing | - | 01-06-20 |
Tood Tucker
HRO | Human Resources Officer | - | 01-07-20 |
Jessica Robison
AUD | Comptroller/Controller/Auditor | - | 01-01-19 |
Bruce Binkowitz
PRN | Corporate Officer/Principal | - | 23-08-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patrick Heron
CHM | Chairman | 53 | 01-04-16 |
Founder | 69 | 01-06-16 | |
Keith Leonard
BRD | Director/Board Member | 62 | 02-09-21 |
Halley Gilbert
BRD | Director/Board Member | 54 | 01-05-20 |
Howard Welgus
BRD | Director/Board Member | 72 | 01-01-16 |
Terrie Curran
BRD | Director/Board Member | 55 | 02-11-20 |
Todd Watanabe
CEO | Chief Executive Officer | 56 | 01-01-16 |
Sue-Jean Lin
BRD | Director/Board Member | 65 | 09-06-21 |
Director/Board Member | 37 | 02-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 115 764 164 | 113 263 795 ( 97,84 %) | 0 | 97,84 % |
Bedrijfsgegevens
Arcutis Biotherapeutics, Inc.
3027 Townsgate Road Suite 300
91361, Westlake Village
+
http://www.arcutis.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+158,98% | 968 mln. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |
- Beurs
- Aandelen
- Koers ARQT
- Onderneming Arcutis Biotherapeutics, Inc.